Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 17, 2022, Alastair Clemow resigned from the board of directors of Applied UV, Inc. (the "Company"). Mr. Clemow was Chairman of the Company's Compensation Committee and a member of the Audit Committee and the Nominating and Corporate Governance Committee. Mr. Clemow resigned as a result of Max Munn nominating and voting for two persons that were not among the Company's nominees. Mr. Clemow's resignation letter is attached hereto as Exhibit 99.1.

On May 17, 2022, Eugene Bauer resigned from the board of directors of the Company. Mr. Bauer was Chairman of the Company's Nominating and Corporate Governance Committee and a member of the Compensation Committee. Mr. Bauer resigned immediately prior to the Company's Annual Shareholders' Meeting when he became aware that he would not be re-elected to the Company's board of directors. Mr. Bauer objected to the fact that Max Munn nominated and voted for two persons that were not among the Company's nominees. Mr. Bauer's resignation letter is attached hereto as Exhibit 99.2.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company convened its virtual Annual Stockholder Meeting (the "Meeting") on May 17, 2022 at 1:00 p.m. Eastern Time. A quorum was present for the Meeting.

At the Meeting, three proposals were submitted to the stockholders for approval as set forth in the definitive Proxy Statement as filed with the SEC on April 7, 2022. As of the record date, March 21, 2022, a total of 13,288,174 shares of common stock of the Company ("Common Stock") were issued and outstanding and entitled to vote. As of the record date, the Company also had 2,000 shares of Series X Super Voting Preferred Stock ("Series X Preferred Stock") issued and outstanding, which is entitled to vote with the Common Stock at a rate of 1,000 votes per share. The Common Stock and the Series X Preferred Stock constitute all of the voting securities of the Company. The holders of record of 10,574,878 shares of Common Stock and 2,000 shares of Series X Preferred Stock were present in person or represented by proxy at said meeting. Such amounts represented approximately 79.6% of the Common Stock entitled to vote at such meeting and approximately 82.3% of Company's total voting power.

At the Meeting, the stockholders approved three of the three proposals submitted. The votes on the proposals were cast as set forth below:



    1.  Proposal No. 1 - Election of directors. The stockholders elected five of
        the six director nominees presented to the stockholders by the Company:
        Max Munn, Alastair Clemow, Eugene Burleson, Dallas Hack and John
        Andrews. A seventh director nominee, Eugen Bauer, resigned from the board
        prior to votes being cast at the annual meeting. Joel Kanter, the
        Company's former Chairman was not re-elected by the stockholders. The
        stockholders also elected the two nominees of Mr. Max Munn: Monica Woo and
        Joseph Luhukay. All of the nominees elected were elected to serve one-year
        terms as directors until successors are elected and qualified.



     Name              For         Withhold      Broker Non-Vote
Eugene Burleson     7,484,560       357,563            2,732,755
Alastair Clemow     7,506,478       335,645            2,732,755
Dallas Hack         7,504,508       337,615             2,732}55
Joel Kanter           683,195       158,928            2,732,755
Max Munn            7,654,336       187,787            2,732,755
John Andrews        7,683,485       158,638            2,732,755
Joseph Luhukay      7,000,000             0                    0
Monica Woo          7,000,000             0                    0


    2.  Proposal No. 2 - Ratification of the Auditors. The stockholders ratified
        and approved the appointment of Mazars USA LLP as the Company's
        independent auditors for the fiscal year ending December 31, 2022.



     For           Against       Abstain      Broker Non-Vote
  10,224,504       127,536       222,838               0


    3.  Proposal No. 3 - Approval of the Amendment to the Company's 2020 Omnibus
        Incentive Plan (the "Plan"). The stockholders approved the (i) increase
        the number of shares of common stock subject to the Plan from 600,000 to
        2,500,000 shares; and (ii) increase the individual limitations on grants
        from 60,000 to 250,000.



     For          Against      Abstain     Broker Non-Vote
  7,447,373       386,022       8,728            2,732,755

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description 99.1 Resignation email dated May 17, 2022 from Alastair Clemow. 99.2 Resignation letter dated May 17, 2022 from Eugene Bauer 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

2

© Edgar Online, source Glimpses